New proton therapy aims to save eyes from removal in large melanoma cases

NCT ID NCT02602756

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested two different proton therapy schedules for people with large choroidal melanomas (eye cancer) that would normally require removal of the eye. The goal was to see if a gentler radiation schedule could control the tumor and avoid severe side effects, allowing patients to keep their eye. The trial was stopped early, but it aimed to improve quality of life by offering a less drastic treatment option.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHOROIDAL MELANOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Centre Antoine Lacassagne

    Nice, 06000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.